Redefining drug development. Replicating human tissues.
VoxCell has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
VoxCell's investors include Archangel Network of Funds, VIATEC, Ventioneers, Spring Activator, New Ventures BC.
VoxCell is headquartered in Victoria, Canada.
Redefining drug development. Replicating human tissues.
VoxCell is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VoxCell — Funding & Investors." VCBacked, September 1, 2026, https://www.vcbacked.co/company/voxcell-bioinnovation. Accessed October 31, 2026.
VCBacked. (2026). VoxCell — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/voxcell-bioinnovation
{{cite web |title=VoxCell — Funding & Investors |url=https://www.vcbacked.co/company/voxcell-bioinnovation |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated